ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter
Trial court denied Company’s motion for a new trial and judgment as a matter of law for unjust enrichmentANI intends...
Neurology
CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development
Consortium initially brings together Lunit, Mindpeak, Imagene AI, Dipath AI, Nucleai, Tivenix and Indica Labs to give biopharma sponsors a...
FDA grants Priority Review to Roche’s Gazyva/Gazyvaro for adults with primary membranous nephropathy
Priority Review decision is based on phase III MAJESTY results, where Gazyva/Gazyvaro achieved significantly higher complete remission rates at two...
Veterinary Referral Center of Central Oregon Expands Access to Advanced Care with Enhanced Medical Travel Program
BEND, OR / ACCESS Newswire / July 14, 2026 / The Veterinary Referral Center of Central Oregon (VRCCO) is proud...
BetterLife Pharma Prioritizes BETR-001 to Lead in Migraine and Headache Disorders, Targeting a Clinically Validated, FDA-Precedented Serotonergic Mechanism
Fully non-hallucinogenic, oral, non-scheduled 5-HT2A neuroplastogen differentiates BETR-001 from every other 5-HT2A agonist program; depression and other psychiatric disorders retained...
Amneal to Report Second Quarter 2026 Results on July 30, 2026
BRIDGEWATER, N.J., July 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced it...
Roche receives CE Mark for blood test to identify tuberculosis infection
The Elecsys IGRA TB test expands global access to tuberculosis infection testing, advancing progress toward the World Health Organization's elimination...
Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine.
Dysport® achieved statistically significant topline Phase III results, meeting primary endpoints in both episodic (E-BEOND) and chronic (C-BEOND) migraineDysport is...
MEGIN Launches Side-by-Side Dual-MEG Hyperscanning Facility at Tsinghua University
Two whole-head MEG systems sit side by side, giving researchers a real-time window into how two brains interact during natural...
Commercialization Application Filed by Hemostemix for the Treatment of Vascular Dementia, Angina and Pain
Calgary, Alberta--(Newsfile Corp. - July 8, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company"), the leading...
Catalyst MedTech Announces Channel Partnership with APQ Health to Expand Access to Advanced Cardiac CT Analysis
PITTSBURGH, July 07, 2026 (GLOBE NEWSWIRE) -- Catalyst MedTech, a leader in nuclear medicine and molecular imaging solutions, today announced...
Beckman Coulter Diagnostics Expands Alzheimer’s Portfolio with CE-Marked p-Tau217 Blood Test and New High-Specificity Research Assay
CE-marked Access p-Tau217 blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of...
Presentation of New Clinical Data on Givinostat in Duchenne Muscular Dystrophy at ICNMD 2026
Phase 3 EPIDYS MRI data quantify givinostat’s potential to preserve functional muscle tissue and reduce fat infiltration in patients with...
Cumulus Neuroscience and Muse by Interaxon Bring Validated At-Home Sleep EEG to CNS Clinical Trials
Collaboration adds brain-based sleep measurement to the NeuLogiq® multi-modal platformBELFAST, Northern Ireland, DUBLIN and TORONTO, July 6, 2026 /PRNewswire/ -- Cumulus...
Xtalks Announces its Life Science Webinar Calendar for July 2026
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, clinical trials, commercialization and HEOR, emerging market, food ingredients...
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
First gene replacement therapy in the EU for broad population with SMA, including children two years and older, teens and...
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s divarasib shows superiority in head-to-head phase III trial against approved KRAS G12C inhibitors in non-small cell lung cancer
Phase III (Krascendo 1) demonstrates best-in-class potential for patients with previously treated advanced KRAS G12C non-small cell lung cancer Divarasib showed...
Magnetic Resonance Imaging (MRI) Market to Reach USD 10.2 Billion by 2036 as AI Reconstruction and Low-Helium Systems Improve Imaging Efficiency | FMI
NEWARK, Del., June 30, 2026 /PRNewswire/ -- The global Magnetic Resonance Imaging (MRI) Market, according to Future Market Insights, is...
FHIMA Celebrates 50th Annual Convention with “Reach for the Stars” Theme, Nationally Recognized Keynote Speakers, and Interactive Healthcare Innovations
Florida's premier health information management conference welcomes hundreds of healthcare professionals to Orlando, July 12–15, 2026.ORLANDO, Fla., June 30, 2026...
How Advocacy Perspectives Can Improve Neurology Research, Upcoming Webinar Hosted by Xtalks
In this free webinar brought to you by Xtalks Life Sciences United (XLSU), see how advocacy perspectives can help shape...